Enrique Grande, MD, PhD, on Targeted Treatment for Thyroid Cancer
Posted: Thursday, March 12, 2020
Enrique Grande, MD, PhD, of MD Anderson Cancer Center, Madrid, discusses the significance of recent findings that showed the efficacy of selpercatinib in RET fusion–positive thyroid cancer and the importance of genetic testing in patients with the malignancy.
Advertisement
Advertisement